Duke, LabCorp Combine Forces to Create The Biomarker Factory

DURHAM, N.C. & BURLINGTON, N.C., Apr 20, 2010 (BUSINESS WIRE) --Duke University Medical Center and Laboratory Corporation of America(R) Holdings (LabCorp(R)) (NYSE: LH) announced today the formation of a joint venture to commercialize new biomarkers. The new entity is designed to speed the

Conversion Right Triggered for LabCorp's Zero Coupon Convertible Subordinated Notes Due 2021

BURLINGTON, N.C., Apr 06, 2010 (BUSINESS WIRE) --Laboratory Corporation of America(R) Holdings (LabCorp(R)) (NYSE: LH) announced today that its Zero Coupon Convertible Subordinated Notes due 2021 (Zero Coupon Notes) may be converted as set forth below.

LabCorp's Zero Coupon Convertible Subordinated Notes Due 2021 to Accrue Contingent Interest

BURLINGTON, N.C., Mar 26, 2010 (BUSINESS WIRE) -- Laboratory Corporation of America(R) Holdings (LabCorp(R)) (NYSE: LH) announced today that for the period of March 12, 2010 to September 11, 2010, its Zero Coupon Convertible Subordinated Notes due 2021 (Zero Coupon Notes) will, subject to the terms

LabCorp is the First National Laboratory to Offer Customers a 21-Marker Genetic Analysis in Combination with a Double-Blind Process on Every Sample for Parentage/Relationship Testing

BURLINGTON, N.C., Mar 26, 2010 (BUSINESS WIRE) -- Laboratory Corporation of America(R) Holdings (LabCorp(R)) (NYSE: LH) announced today that it is the first national laboratory to offer customers a 21-marker genetic analysis in combination with a double-blind process for parentage/relationship

LabCorp is Scheduled to Present at the Barclays Capital 2010 Global Healthcare Conference

BURLINGTON, N.C., Mar 16, 2010 (BUSINESS WIRE) -- Laboratory Corporation of America(R) Holdings (LabCorp(R)) (NYSE: LH) today announced that David P. King, Chairman and Chief Executive Officer, is scheduled to speak at the Barclays Capital 2010 Global Healthcare Conference in Miami Beach, FL.

LabCorp is Scheduled to Speak at RBC Capital Markets' Healthcare Conference

BURLINGTON, N.C., Feb 23, 2010 (BUSINESS WIRE) -- Laboratory Corporation of America(R) Holdings (LabCorp(R)) (NYSE: LH) today announced that William B. (Brad) Hayes, Executive Vice President and Chief Financial Officer, is scheduled to speak at the RBC Capital Markets' Healthcare Conference in New

LabCorp Announces New Holder of the Noncontrolling Interest in the Company's Ontario, Canada Joint Venture

BURLINGTON, N.C., Feb 17, 2010 (BUSINESS WIRE) -- Laboratory Corporation of America(R) Holdings (LabCorp(R)) (NYSE:LH) announced today that on February 8, 2010 it completed a transaction to acquire the partnership units from the holder of the noncontrolling interest in the Company's Ontario, Canada

Laboratory Corporation of America(R) Holdings Announces 2009 Fourth Quarter and Full Year Results

Revenue Growth Drives Adjusted EPS of $1.16 and Operating Cash Flow of $224.7 Million BURLINGTON, N.C., Feb 11, 2010 (BUSINESS WIRE) -- Laboratory Corporation of America(R) Holdings (LabCorp(R)) (NYSE: LH) today announced results for the quarter and year ended December 31, 2009.

LabCorp is Scheduled to Present at the Jefferies 2010 Global Healthcare Services Conference

BURLINGTON, N.C., Jan 19, 2010 (BUSINESS WIRE) -- Laboratory Corporation of America(R) Holdings (LabCorp(R)) (NYSE:LH) today announced that David P. King, Chairman and Chief Executive Officer, is scheduled to speak at the Jefferies 2010 Global Healthcare Services Conference in New York, NY.

Conversion Right Triggered for LabCorp's Zero Coupon Convertible Subordinated Notes Due 2021

BURLINGTON, N.C., Jan 05, 2010 (BUSINESS WIRE) -- Laboratory Corporation of America Holdings (LabCorp) (NYSE: LH) announced today that its Zero Coupon Convertible Subordinated Notes due 2021 (Zero Coupon Notes) may be converted as set forth below. The Zero Coupon Notes are convertible into cash and